These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19558507)

  • 1. Prognostic relevance of cytogenetic abnormalities in primary myelofibrosis: comparison of recent reports from Japan, the Mayo Clinic and MD Anderson Cancer Center.
    Tefferi A
    Eur J Haematol; 2009 Oct; 83(4):290-1. PubMed ID: 19558507
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
    Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
    Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
    Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
    Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cytogenetic abnormality in primary myelofibrosis.
    Bae SY; Kim JS; Lee KN; Lee CK; Kim YK; Yoon SY; Lim CS; Cho YJ; Choi CW; Kim WY
    Cancer Genet Cytogenet; 2009 Oct; 194(1):65-6. PubMed ID: 19737657
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.
    Sancho JM; Ribera JM; Granada I; Navarro JT; Millá F; Feliu E
    Haematologica; 2000 May; 85(5):554-5. PubMed ID: 10800180
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognosis and survivorship in primary myelofibrosis.
    Reilly JT
    Am J Hematol; 2010 Jan; 85(1):4-5. PubMed ID: 20029947
    [No Abstract]   [Full Text] [Related]  

  • 7. Conventional cytogenetics in myelofibrosis: literature review and discussion.
    Hussein K; Van Dyke DL; Tefferi A
    Eur J Haematol; 2009 May; 82(5):329-38. PubMed ID: 19141119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic studies in proliferative disorders.
    Padeh B; Bianu G; Schaki R; Akstein E
    Isr J Med Sci; 1965 Jul; 1(4):795-7. PubMed ID: 5856120
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromosome aberrations including der(6)t(2;6)(p15;p21.3) and der(22)t(3;22)(p21;p11) in the evolution of essential thrombocythemia to myelofibrosis with myeloid metaplasia.
    Lazarevic V; Andersson C; Wahlin A; Golovleva I
    Cancer Genet Cytogenet; 2006 Feb; 165(1):87-9. PubMed ID: 16490605
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.
    Tefferi A; Jimma T; Gangat N; Vaidya R; Begna KH; Hanson CA; Van Dyke DL; Caramazza D; Pardanani A
    Blood; 2011 Oct; 118(17):4595-8. PubMed ID: 21881047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosis.
    Pantic M; Pfeifer D; Kapp-Schwoerer S; Ihorst G; Becker H; Zeiser R; Duyster J; Schmitt-Graeff A
    Leukemia; 2019 Dec; 33(12):2956-2962. PubMed ID: 31350530
    [No Abstract]   [Full Text] [Related]  

  • 12. Constitutional trisomy 8 mosaicism in primary myelofibrosis: relevance to clinical practice and warning for trisomy 8 studies.
    Maserati E; Pressato B; Valli R; Patitucci F; Lo Curto F; Pasquali F; Minelli A; Danesino C; Marchetti M; Barosi G
    Cancer Genet Cytogenet; 2007 Nov; 179(1):79-81. PubMed ID: 17981220
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical progress in idiopathic myelofibrosis.
    Okamura T
    Intern Med; 2003 Jun; 42(6):461-2. PubMed ID: 12857040
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.
    Okamura T; Kinukawa N; Niho Y; Mizoguchi H
    Int J Hematol; 2001 Feb; 73(2):194-8. PubMed ID: 11372731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary chronic myelofibrosis in the Japanese population].
    Okamura T; Shimoda K
    Rinsho Ketsueki; 2005 May; 46(5):330-8. PubMed ID: 16444966
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis.
    Tefferi A; Lasho TL; Finke C; Gangat N; Hanson CA; Ketterling RP; Pardanani A
    Leukemia; 2018 Mar; 32(3):837-839. PubMed ID: 29089644
    [No Abstract]   [Full Text] [Related]  

  • 17. TP53 mutation is rare in primary myelofibrosis.
    Greaves WO; Verma S; Bisrat T; Strati P; Rahimi H; Paladugu AV; Luthra R; Patel KP; Medeiros LJ; Yao H; Pierce S; Bueso-Ramos CE; Verstovsek S
    Leuk Lymphoma; 2013 Jul; 54(7):1552. PubMed ID: 23121011
    [No Abstract]   [Full Text] [Related]  

  • 18. An interesting case of pachydermoperiostosis with idiopathic myelofibrosis associated with monosomy 22.
    Arikan S; Sen I; Bahceci M; Tuzcu A; Ayli M
    Int J Dermatol; 2009 Aug; 48(8):882-5. PubMed ID: 19659869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. About primary myelofibrosis.
    Ozsoylu S
    Eur J Haematol; 1988 Nov; 41(5):509. PubMed ID: 3208874
    [No Abstract]   [Full Text] [Related]  

  • 20. [Malignant myelofibrosis].
    Krc I; Rozhold O; Vojácek K
    Vnitr Lek; 1981 May; 27(5):465-8. PubMed ID: 7245631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.